ATE470351T1 - Nichtmenschliches tiermodell, das nicht auf eine immunopotenzierende synthetische verbindung anspricht - Google Patents

Nichtmenschliches tiermodell, das nicht auf eine immunopotenzierende synthetische verbindung anspricht

Info

Publication number
ATE470351T1
ATE470351T1 AT02803565T AT02803565T ATE470351T1 AT E470351 T1 ATE470351 T1 AT E470351T1 AT 02803565 T AT02803565 T AT 02803565T AT 02803565 T AT02803565 T AT 02803565T AT E470351 T1 ATE470351 T1 AT E470351T1
Authority
AT
Austria
Prior art keywords
mouse
gene
tlr7
synthetic compound
animal model
Prior art date
Application number
AT02803565T
Other languages
English (en)
Inventor
Shizuo Akira
Hideyuki Tomizawa
Takashi Yamaoka
Original Assignee
Japan Science & Tech Agency
Dainippon Sumitomo Pharma Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Japan Science & Tech Agency, Dainippon Sumitomo Pharma Co filed Critical Japan Science & Tech Agency
Application granted granted Critical
Publication of ATE470351T1 publication Critical patent/ATE470351T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
    • A01K67/027—New or modified breeds of vertebrates
    • A01K67/0275—Genetically modified vertebrates, e.g. transgenic
    • A01K67/0276—Knock-out vertebrates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/8509—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells for producing genetically modified animals, e.g. transgenic
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/07—Animals genetically altered by homologous recombination
    • A01K2217/075—Animals genetically altered by homologous recombination inducing loss of function, i.e. knock out
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2227/00—Animals characterised by species
    • A01K2227/10—Mammal
    • A01K2227/105—Murine
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00—Animals characterised by purpose
    • A01K2267/03—Animal model, e.g. for test or diseases
    • A01K2267/0337—Animal models for infectious diseases

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Environmental Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Public Health (AREA)
  • Toxicology (AREA)
  • Physics & Mathematics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cell Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Animal Husbandry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT02803565T 2001-11-22 2002-11-22 Nichtmenschliches tiermodell, das nicht auf eine immunopotenzierende synthetische verbindung anspricht ATE470351T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2001358295 2001-11-22
PCT/JP2002/012234 WO2003043588A1 (en) 2001-11-22 2002-11-22 Nonhuman model animal unresponsive to immunopotentiating synthetic compound

Publications (1)

Publication Number Publication Date
ATE470351T1 true ATE470351T1 (de) 2010-06-15

Family

ID=19169496

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02803565T ATE470351T1 (de) 2001-11-22 2002-11-22 Nichtmenschliches tiermodell, das nicht auf eine immunopotenzierende synthetische verbindung anspricht

Country Status (6)

Country Link
US (1) US7608750B2 (de)
EP (1) EP1459727B1 (de)
AT (1) ATE470351T1 (de)
CA (1) CA2468011C (de)
DE (1) DE60236686D1 (de)
WO (1) WO2003043588A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2536249A1 (en) 2003-08-25 2005-03-10 3M Innovative Properties Company Delivery of immune response modifier compounds
US8252302B2 (en) * 2007-06-11 2012-08-28 Edge Therapeutics, Inc. Methods and compositions to treat hemorrhagic conditions of the brain
US10092524B2 (en) 2008-06-11 2018-10-09 Edge Therapeutics, Inc. Compositions and their use to treat complications of aneurysmal subarachnoid hemorrhage
AU2010250923A1 (en) * 2009-05-21 2011-11-17 Astrazeneca Ab Novel pyrimidine derivatives and their use in the treatment of cancer and further diseases
EP2508190B1 (de) * 2009-12-03 2021-06-02 Aureo Co., Ltd. Makrophagen-phagozytose-aktivierende zusammensetzung und/oder zusammensetzung zur förderung der zytokinproduktion in makrophagen
AU2012240131B2 (en) 2011-04-05 2017-07-20 Edge Therapeutics Intraventricular drug delivery system for improving outcome after a brain injury affecting cerebral blood flow
CN113373178A (zh) * 2021-08-13 2021-09-10 上海南方模式生物科技股份有限公司 一种tlr8基因人源化动物模型的构建方法及应用
WO2024012578A1 (zh) * 2022-07-15 2024-01-18 百奥赛图(北京)医药科技股份有限公司 一种tlr7和/或tlr8基因人源化修饰的非人动物

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1366077B1 (de) * 2000-09-15 2011-05-25 Coley Pharmaceutical GmbH Verfahren zum hochdurchsatzscreening von auf cpg basierenden immunagonisten und -antagonisten
DK1719511T3 (da) 2001-11-16 2009-04-14 Coley Pharm Group Inc N-[4-(4-amino-2-ethyl-1H-imidazo[4,5-c]quinolin-1-yl)butyl]methansulfonamid, en farmaceutisk sammensætning omfattende samme, og anvendelse deraf

Also Published As

Publication number Publication date
EP1459727A4 (de) 2006-09-06
DE60236686D1 (de) 2010-07-22
CA2468011C (en) 2012-04-10
US20050235372A1 (en) 2005-10-20
US7608750B2 (en) 2009-10-27
EP1459727B1 (de) 2010-06-09
JPWO2003043588A1 (ja) 2005-03-10
EP1459727A1 (de) 2004-09-22
CA2468011A1 (en) 2003-05-30
JP4493336B2 (ja) 2010-06-30
WO2003043588A1 (en) 2003-05-30

Similar Documents

Publication Publication Date Title
Niedermeyer et al. Expression of the fibroblast activation protein during mouse embryo development.
Kandul et al. Assessment of a split homing based gene drive for efficient knockout of multiple genes
Kanki et al. High-efficiency CAG-FLPe deleter mice in C57BL/6J background
KR102658529B1 (ko) 조작된 면역글로불린 람다 경쇄 유전자좌를 갖는 비인간 동물
Theis et al. Endothelium‐specific replacement of the connexin43 coding region by a lacZ reporter gene
DE69929324D1 (de) TRANSGENE Mäuse MIT VERÄNDERTER APOLIPOPROTEIN E-EXPRESSION UND TESTVERFAHREN.
DE60236686D1 (de) Nichtmenschliches tiermodell, das nicht auf eine immunopotenzierende synthetische verbindung anspricht
Lee et al. Current progress of genome editing in livestock
ATE381614T1 (de) Bildung von xenogenen antikörpern
JP2015523863A5 (de)
US7700356B2 (en) System for gene targeting and producing stable genomic transgene insertions
HRP20240855T1 (hr) Neljudske životinje koje imaju humanizirani gen cd274 iz diferencijacijske skupine
Imayoshi et al. A multifunctional teal-fluorescent Rosa26 reporter mouse line for Cre-and Flp-mediated recombination
US7473557B2 (en) Method for targeting transcriptionally active loci
Lin et al. Simple and rapid determination of homozygous transgenic mice via in vivo fluorescence imaging
Eferl et al. Simultaneous generation of fra‐2 conditional and fra‐2 knock‐out mice
Andrusaite et al. Should we be more cre‐tical? A cautionary tale of recombination
EA030305B1 (ru) Животная модель болезни краббе
Kratochwil et al. The Cre/Lox system to assess the development of the mouse brain
JP2011518566A5 (de)
Meng et al. Surfactant protein A promoter directs the expression of Cre recombinase in brain microvascular endothelial cells of transgenic mice
Hamada et al. Role of asymmetric signals in left–right patterning in the mouse
EP1712126A4 (de) Transgener vogel und verfahren zu seiner herstellung
DE60039964D1 (de) Modellmaus, die nicht auf bakterielle zellkomponenten anspricht.
WO2005037994A3 (en) Transgenic rodents selectively expressing human b1 bradykinin receptor protein

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties